Skip to content

Human study for investigating the effects Chrysanthemum flower extract on body fat level and related metabolism in obese adults

Human study for investigating the effects Chrysanthemum flower extract on body fat level and related metabolism in obese adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005429
Enrollment
88
Registered
2020-09-24
Start date
2020-09-18
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Control group takes 2 placebo capsules and test group takes 2 Chrysanthemum flower extract capsules once for two times a day for 12 weeks.

Sponsors

Ewha Womens University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subject who voluntarily agree to participate and signs informed consent form 2) Aged more than 19 years and less than 65 years, women and men 3) Those with waistlines greater than 90 cm for men and 85 cm for women. 4) Metabolism score is above 1.332 5) Those who can follow the diet and guidelines during the intervention period

Exclusion criteria

Exclusion criteria: 1) Those who have taken or are likely to take medications that affect body weight, blood sugar, lipids, hypertension, or intestinal health within one month of the first visit : appetite suppressants/accelerators, hormone drugs (female hormones, male hormones, thyroid hormones, steroid drugs, etc.), TCA drugs, laxatives, antidepressants, hypoglycemic agent, Lipidlowering drugs, inflammatory bowel disease drug, diuretics, ß-blocker etc. 2) Those who have taken antibiotics within 2 months of the first visit or are likely to take it during the study 3) Subject diagnosed with the following diseases ? Liver dysfunction or hepatobiliary disease ? Renal dysfunction ? Hyperthyroidism and hypofunction, Cushing's syndrome ? If you have a medical history of severe central nervous system disorders that require hospitalization or medication ? Those with severe cerebrovascular disease, heart disease. However, dizziness If there is no medical history, it may be excluded at the discretion of the researcher. ? Malignant tumor, lung disease, musculoskeletal disease, immune system or inflammatory disease ? A person who complains of gastrointestinal disorders or severe gastrointestinal symptoms such as heartburn, indigestion or severe constipation 4) Those who have experience in surgery such as gastroplasty or enterectomy for weight loss 5) Those who have participated in a commercial obesity program in the past 3 months or have had a calorie-restricted diet treatment 6) Those who have irregular eating habits and lifestyle 7) Those who have difficulty complying with dietary and lifestyle guidelines during the study 8) Those who have continuously consumed dietary supplements or herbal medicines affecting their weight, blood sugar, lipids, and hypertension within one month of their first visit. 9) Those who have consistently consumed foods, Probiotics 10) Those who have had a weight change of 5% or more within the last 3 months 11) Those who have good quality of usual meals (Recommended Food Score > 36) 12) Those who continuously exercises high intensity 13) Those who have hypersensitivity to the test / placebo food or ingredients or have experienced severe food allergic reactions. 14) Participants in other human application research within 1 month of first visit 15) Pregnant or lactating women 16) Those who have difficulty using a smartphone or computer 17) If the researcher deems inappropriate to participate in this study

Design outcomes

Primary

MeasureTime frame
Body fat improvement indicator

Secondary

MeasureTime frame
Adverse events;Vital signs

Countries

Korea, Republic of

Contacts

Public ContactEunok Lee

Ewha Womens University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026